Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer
Background. The purpose of this study was to analyze SUMO activating enzyme subunit 1 (SAE1) expression in breast cancer (BC). Through bioinformatics analysis and in vitro experiments, the biological function and possibly associated signal pathways of SAE1 in BC were further analyzed. Methods. Bioin...
Saved in:
Main Authors: | Hong Liu, Jing Wang, Yunhai Li, Feng Luo, Lei Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | The Breast Journal |
Online Access: | http://dx.doi.org/10.1155/2024/2981722 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Anti-SAE1 Dermatomyositis
by: Max de Vries, et al.
Published: (2022-01-01) -
Poorly differentiated thyroid cancer: Clinical, pathological, mutational, and outcome analysis
by: Amit Agarwal, et al.
Published: (2024-12-01) -
Multipurpose zero watermarking algorithm for medical image based on SVD and SAE
by: Jieli SUN, et al.
Published: (2017-11-01) -
The role of HSPA14 in breast cancer: implications for tumorigenesis, immune response modulation, and personalized therapies
by: Ruipeng Zhao, et al.
Published: (2025-12-01) -
The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis
by: Javier Conde, et al.
Published: (2025-01-01)